APA

Damme M., Stroobants S., Walkley S. U., Lüllmann-Rauch R., D'Hooge R., Fogh J., Saftig P., Lübke T. & Blanz J. (20110307). Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis. : Journal of neuropathology and experimental neurology.

Chicago

Damme Markus, Stroobants Stijn, Walkley Steven U, Lüllmann-Rauch Renate, D'Hooge Rudi, Fogh Jens, Saftig Paul, Lübke Torben and Blanz Judith. 20110307. Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis. : Journal of neuropathology and experimental neurology.

Harvard

Damme M., Stroobants S., Walkley S. U., Lüllmann-Rauch R., D'Hooge R., Fogh J., Saftig P., Lübke T. and Blanz J. (20110307). Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis. : Journal of neuropathology and experimental neurology.

MLA

Damme Markus, Stroobants Stijn, Walkley Steven U, Lüllmann-Rauch Renate, D'Hooge Rudi, Fogh Jens, Saftig Paul, Lübke Torben and Blanz Judith. Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis. : Journal of neuropathology and experimental neurology. 20110307.